Enalapril: a well-tolerated and efficacious agent for the paediatric hypertensive patient.
Enalapril, either alone or with a diuretic, was administered to 14 children with various renal diseases and hypertension. Five were transplant recipients on immunosuppressive agents. No adverse clinical or laboratory experiences were encountered. Renal function improved in seven children. Normal blood pressure for age was achieved in all 14 children. However, eight children required the addition of a diuretic. In four children blood pressure remained normal despite a reduction in the dose of enalapril. Enalapril was efficacious as a once per day agent. Concomitant ingestion of food did not attenuate the blood pressure-lowering effect of enalapril.
D000293:Adolescent; D000806:Angiotensin-Converting Enzyme Inhibitors; D002648:Child; D002675:Child, Preschool; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007223:Infant; D008297:Male
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril